MediWound to launch Phase III trial for venous leg ulcers
1. MediWound initiates Phase III trial for venous leg ulcer treatment. 2. Success in trials could significantly boost MDWD's market position.
FAQ
Why Bullish?
Positive trial results could lead to FDA approval, similar to past biotech successes like AcelRx.
How important is it?
The article highlights critical advancements that could improve MDWD's visibility and valuation.
Why Long Term?
Phase III trials often take time; potential impacts felt over several quarters.